Biotech news on June 18, 2026

1. 0123:03 UTC

   IQVIA buys lab assets Charles River agreed to sell earlier this year

   3 outlets · first: Sacbee Funding

   Machine summary IQVIA is purchasing laboratory assets that Charles River had agreed to divest earlier in the year.

   Reported by Sacbee, kansascity.com and miamiherald.com.

   • IQVIA Holdings

   Full coverage: every report, when each was published, and who was named (3 outlets)

2. 0205:30 UTC

   WuXi Biologics says Suzhou biosafety testing center passed fourth EMA GMP inspection

   2 outlets · first: Pr Newswire Pharma Mostly press releases

   Machine summary WuXi Biologics announced that its Biosafety Testing Center in Suzhou passed a European Medicines Agency Good Manufacturing Practice inspection with zero critical findings, the fourth time the facility has received an EMA GMP certificate. The company said the inspection supported European Union marketing authorization applications for 19 biologics from 13 clients.

   1. WuXi Biologics said its Suzhou Biosafety Testing Center passed an EMA GMP inspection with zero critical findings.
   2. The company said this was the fourth time the facility received an EMA GMP certificate.
   3. WuXi Biologics said the inspection supported EU marketing authorization applications for 19 biologics from 13 clients.
   4. The company said the products span modalities including antibodies, enzymes and fusion proteins.
   5. The four-day inspection, WuXi Biologics said, examined personnel, computerized systems, standard operating procedures, testing methods, facilities and equipment, and quality management.

   Reported by Pr Newswire and pannaphat.me.

   • European Medicines Agency
   • WuXi Biologics

3. 0320:15 UTC

   CosmoFarm Hits $60M Run-Rate with 80+ New Pharmacies, AI Automation

   2 outlets · first: finanznachrichten.de Pharma

   Machine summary Cosmos Health's pharma wholesale arm CosmoFarm reported over $15M in Q2 2026 revenue, representing a $60M+ annualized run-rate. CosmoFarm added over 80 pharmacies and expanded AI automation and facility capacity, according to Cosmos Health Inc.

   1. CosmoFarm recorded over $15 million in revenue for Q2 2026, translating to a $60+ million annualized run-rate.
   2. During the period, the subsidiary expanded its distribution network by adding over 80 new pharmacies.
   3. Cosmos Health is investing in new robotic automation and artificial intelligence systems for procurement, inventory management, and order fulfillment.
   4. The facility is being expanded to accommodate higher volumes and continued network growth.
   5. Existing automated infrastructure includes ROWA and SSI SCHÄFER A-frame robotic systems.

   Reported by finanznachrichten.de and manilatimes.net.

   • Cosmos Health Inc.
   • SSI SCHÄFER
   • ROWA

4. 0403:15 UTC

   Biotech desk: QURE, LNAI, FTH, ELTX among top gainers

   1 outlet · first: Rttnews Clinical trial

   Machine summary Key facts from the reports:

   1. QURE rallied on an AMT-130 update, according to the report
   2. LNAI was reported on track

   Reported by Rttnews.

   • AMT-130
   • LNAI

5. 0514:15 UTC

   Endoscopic robotics company Channel Robotics raises $4.6M

   1 outlet · first: Pr Newswire Funding Mostly press releases

   Machine summary Channel Robotics has raised $4.6M in total funding to advance a handheld, AI‑driven endoscopic robotic platform. The funding follows Channel Robotics raising $4.6 million.

   1. Channel Robotics closed a $2.5 million Seed+ round led by True Ventures, bringing total funding to $4.6 million.
   2. The company previously raised a $2.1 million Seed round with participation from Defined VC and Old Line Capital Partners.
   3. Its patented handheld AI-enabled robotic platform is designed to deliver robotic dexterity through existing flexible endoscopes without capital-intensive systems.
   4. The funding will support product development, regulatory advancement, and commercialization preparation, per the company.
   5. Co-founders include Michael Yip, PhD, and an unnamed co-founder identified as “Philip” with clinical expertise.

   Reported by Pr Newswire.

   • Channel Robotics
   • Old Line Capital Partners
   • Defined VC
   • True Ventures

Each summary and its key facts are a machine summary of the reports linked under it; the outlets, times and counts come from those reports' own records. How a rundown is built.